What does plasma collection centers — stock-based comp mean?

Reflects the non-cash expense related to equity-based awards granted to employees specifically supporting the plasma collection segment. This metric is used to understand the true labor cost and alignment of incentives within the segment. It is often excluded from adjusted EBITDA to show cash-based operational performance.

ADMA Biologics ADMA Plasma Collection Centers — Stock-Based Comp

Other segment segments

ADMA Bio Manufacturing

$0—

Similar metrics at other companies

SRPTAll Other Segments — Stock-Based Comp

$29.4M-29.0%

IMAXEmployee Benefits And Share Based Compensation

$5.79M+9.8%

OPCHStock-Based Comp

1.7%+0.5pp

HXLComposite Materials — Stock-Based Comp

$3.4M+13.3%

BCRXStock-Based Comp

$1.21M+74.0%

APA

APAMSharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1

$8.39M-1.3%

Other financials

Income statement

See full

Revenue$114.5M-0.3%

Gross profit$80.8M+32.2%

Operating income$58.3M+67.1%

Net income$45.3M+68.5%

EPS (diluted)$0.19+72.7%

Balance sheet

See full

Cash & equivalents$138.2M+92.9%

Total debt$204.4M+2,055%

Total equity$390.3M+4.5%

Total assets$665.2M+30.3%

Cash flow

See full

Operating cash flow$58.2M+396%

CapEx$2.5M-45.9%

Free cash flow$55.7M+329%

Valuation

See full

Market cap$2.01B-54.5%

Enterprise value$2.08B-52.5%

P/E12.2×-9.2×

P/S4×-5.7×

Profitability

See full

Gross margin61.3%+8.7pp

Operating margin42.1%+9.0pp

Net margin32.4%-12.6pp

FCF margin21.2%+1.4pp

Returns & leverage

See full

Return on equity43.3%-35.2pp

Debt / equity0.5×+0.5×

Current ratio7×+0.4×

Where this comes from

Reported directly by ADMA Biologics in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about ADMA Biologics's plasma collection centers — stock-based comp.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is ADMA Biologics's plasma collection centers — stock-based comp?: ADMA Biologics (ADMA) reported plasma collection centers — stock-based comp of $1.06M in Q1 2026.
What does plasma collection centers — stock-based comp mean?: Reflects the non-cash expense related to equity-based awards granted to employees specifically supporting the plasma collection segment. This metric is used to understand the true labor cost and alignment of incentives within the segment. It is often excluded from adjusted EBITDA to show cash-based operational performance.